Enliven: Journal of Dietetics Research and Nutrition

Effect of Litramine (IQP-G-002AS) on Weight Loss in Overweight and Obese US Population: A Randomised, Double-Blind, Placebo-Controlled Study
Author(s): Jay K Udani, Pee-Win Chong, Emily Teng, and Joerg Gruenwald

Background:
Previous studies have shown that Litramine was effective in weight loss for overweight and obese subjects.

Objective:
To further validate the weight loss effect of Litramine compared to placebo in US population.

Methods:
Double-blind, randomised, placebo-controlled study conducted over 14 weeks including 2 weeks run-in. Overweight and obese subjects were randomly
allocated to either Litramine™ or the placebo group. Primary endpoint was the comparison of the difference in body weight (lbs) at baseline and after 12
weeks of treatment with Litramine™ versus placebo.

Results:
The Litramine group lost significantly more weight in comparison to the placebo group who gained weight instead (-2.53 lbs vs 2.56 lbs, p<0.001).

Conclusion:
Litramine is safe and efficacious for body weight loss.